Characterization of gastrins and their receptor in solid human gastric adenocarcinomas

References

• Orlando LA, Lenard L, Orlando RC. Chronic hypergastrinemia: causes and consequences. Dig Dis Sci 2007;52:2482–9.
   PubMed Web of Science ®Google Scholar
• Fossmark R, Qvigstad G, Waldum HL. Gastric cancer: Animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol 2008;14:1646–51.
   PubMed Web of Science ®Google Scholar
• Burkitt MD, Varro A, Pritchard DM. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 2009;15:1–16.
   PubMed Web of Science ®Google Scholar
• Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36–47.
   PubMed Web of Science ®Google Scholar
• Cui G, Takaishi S, Ai W, Betz KS, Florholmen J, Koh TJ, et al. Gastrin-induced apoptosis contributes to carcinogenesis in the stomach. Lab Invest 2006;86:1037–51.
   PubMedGoogle Scholar
• Watson SA, Durrant LG, Crosbie JD, Morris DL. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin. Int J Cancer 1989;43:692–6.
   PubMed Web of Science ®Google Scholar
• van Solinge WW, Rehfeld JF. Co-transcription of the gastrin and cholecystokinin genes with selective translation of gastrin mRNA in a human gastric carcinoma cell line. FEBS Lett 1992;309:47–50.
   PubMed Web of Science ®Google Scholar
• Ishizuka J, Martinez J, Townsend CM Jr, Thompson JC. The effect of gastrin on growth of human stomach cancer cells. Ann Surg 1992;215:528–34.
   PubMed Web of Science ®Google Scholar
• Iwase K, Evers BM, Hellmich MR, Guo YS, Higashide S, Kim HJ, et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology 1997;113:782–90.
   PubMed Web of Science ®Google Scholar
• Zhou JJ, Chen ML, Zhang QZ, Hu JK, Wang WL. Coexpression of cholecystokinin- B/gastrin receptor and gastrin gene in human gastric tissues and gastric cancer cell line. World J Gastroenterol 2004;10:791–4.
   PubMedGoogle Scholar
• Pradeep A, Sharma C, Sathyanarayana P, Albanese C, Fleming JV, Wang TC, et al. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells. Oncogene 2004;23:3689–99.
   PubMedGoogle Scholar
• Subramaniam D, Ramalingam S, May R, Dieckgraefe BK, Berg DE, Pothoulakis C, et al. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms. Gastroenterology 2008;134:1070–82.
   PubMedGoogle Scholar
• Rehfeld JF, Bardram L, Hilsted L. Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res 1989;49:2840–3.
   PubMed Web of Science ®Google Scholar
• van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993;104:1099–107.
   PubMed Web of Science ®Google Scholar
• van Solinge WW, Odum L, Rehfeld JF. Ovarian cancers express and process progastrin. Cancer Res 1993;53:1823–8.
   PubMed Web of Science ®Google Scholar
• Goetze JP, Nielsen FC, Burcharth F, Rehfeld JF. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer 2000;88:2487–94.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, van Solinge WW. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994;63:295–347.
   PubMed Web of Science ®Google Scholar
• Reubi JC. Targeting CCK receptors in human cancers. Curr Top Med Chem 2007;7:1239–42.
   PubMedGoogle Scholar
• Kochman ML, DelValle J, Dickinson CJ, Boland CR. Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem Biophys Res Commun 1992;189:1165–9.
   PubMed Web of Science ®Google Scholar
• Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993;34:90–5.
   PubMed Web of Science ®Google Scholar
• Lee HK, Lee HJ, Hur K, Lee HS, Kim WH, Michaeli D, et al. Growth effect of gastrin on gastric cancer and its clinical implications for gastric cancer surgery. Oncol Rep 2005;14:383–8.
   PubMedGoogle Scholar
• Henwood M, Clarke PA, Smith AM, Watson SA. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 2001;88:564–8.
   PubMedGoogle Scholar
• Hur K, Kwak MK, Lee HJ, Park DJ, Lee HK, Lee HS, et al. Expression of gastrin and its receptor in human gastric cancer tissues. J Cancer Res Clin Oncol 2006;132:85–91.
   PubMed Web of Science ®Google Scholar
• Stephens MR, Hopper AN, Lewis WG, Blackshaw G, Edwards P, Osborne B, et al. Prognostic significance of gastrin expression in patients undergoing R0 gastrectomy for adenocarcinoma. Gastric Cancer 2007;10:159–66.
   PubMedGoogle Scholar
• Goetze JP, Gore A, Møller CH, Steinbrüchel D, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004;18:1928–30.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972;30:221–32.
   PubMed Web of Science ®Google Scholar
• Stadil F, Rehfeld JF. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol 1973;8:101–12.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Gingras ML, Bardram L, Hilsted L, Goetze JP, Poitras P. The Zollinger-Ellison syndrome and mismeasurement of gastrin. Gastroenterology 2011;140:1444–53.
   PubMed Web of Science ®Google Scholar
• Hilsted L, Rehfeld JF. Measurement of precursors for alpha-amidated hormones by radioimmunoassay of glycine-extended peptides after trypsin-carboxypeptidase B cleavage. Anal Biochem 1986;152:119–26.
   PubMed Web of Science ®Google Scholar
• Hilsted L, Rehfeld JF. Alpha-carboxyamidation of antral progastrin. Relation to other post-translational modifications. J Biol Chem 1987;262:16953–7.
   PubMed Web of Science ®Google Scholar
• Hansen TO, Borup R, Marstrand T, Rehfeld JF, Nielsen FC. Cholecystokinin-2 receptor mediated gene expression in neuronal PC12 cells. J Neurochem 2008;104:1450–65.
   PubMedGoogle Scholar
• Laabich A, Cooper NG. Regulation of calcium/calmodulin-dependent protein kinase II in the adult rat retina is mediated by ionotropic glutamate receptors. Exp Eye Res 1999;68:703–13.
   PubMedGoogle Scholar
• Hannibal J, Georg B, Fahrenkrug J. Melanopsin changes in neonatal albino rat independent of rods and cones. Neuroreport 2007;18:81–5.
   PubMedGoogle Scholar
• Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem 1998;44:991–1001.
   PubMed Web of Science ®Google Scholar
• Hannibal J, Hundahl C, Fahrenkrug J, Rehfeld JF, Friis-Hansen L. Cholecystokinin (CCK) expressing neurons in the suprachiasmatic nucleus: innervation, light responsiveness and entrainment in CCK-deficient mice. Eur J Neurosci 2010;32:1006–17.
   PubMed Web of Science ®Google Scholar
• Grabowska AM, Watson SA. Role of gastrin peptides in carcinogenesis. Cancer Lett 2007;257:1–15.
   PubMed Web of Science ®Google Scholar
• Blackmore M, Hirst BH. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br J Cancer 1992;66:32–8.
   PubMed Web of Science ®Google Scholar
• Seva C, Dickinson CJ, Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994;265:410–12.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. Gastrins in serum. Scand J Gastroenterol 1973;8:577–83.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Stadil F, Vikelsoe J. Immunoreactive gastrin components in human serum. Gut 1974;15:102–11.
   PubMed Web of Science ®Google Scholar
• Konturek PC, Konturek SJ, Bielanski W, Kania J, Zuchowic Z, Hartwich A, et al. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients. Dig Dis Sci 2003;48:2005–17.
   PubMedGoogle Scholar
• Brett BT, Smith SC, Bouvier CV, Michaeli D, Hochhauser D, Davidson BR, et al. Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. J Clin Oncol 2002;20:4225–31.
   PubMed Web of Science ®Google Scholar
• Gilliam AD, Watson SA. Emerging biological therapies for pancreatic carcinoma. Eur J Surg Oncol 2002;28:370–8.
   PubMedGoogle Scholar
• Ajani JA, Hecht JR, Ho L, Baker J, Oortgiesen M, Eduljee A, et al. An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5- fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 2006;106:1908–16.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Goetze JP. Gastrin vaccination against gastrointestinal and pancreatic cancer. Scand J Gastroenterol 2006;41:122–3.
   PubMed Web of Science ®Google Scholar
• Buttar NS, Wang KK. Mechanisms of disease: Carcinogenesis in Barrett's esophagus. Nat Clin Pract Gastroenterol Hepatol 2004;1:106–12.
   PubMedGoogle Scholar
• Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard DM, et al. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 2003;124:615–25.
   PubMed Web of Science ®Google Scholar
• Black JW. Reflections on some pilot trials of gastrin receptor blockade in pancreatic cancer. Eur J Cancer 2009;45:360–4.
   PubMedGoogle Scholar